Digoxin and Mortality in Patients With Atrial Fibrillation

Renato D Lopes1, Roberto Rordorf2, Gaetano M De Ferrari2

  • 1Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

Insights

Digoxin use in atrial fibrillation (AF) patients is linked to increased mortality, especially with higher serum concentrations (≥1.2 ng/ml). Starting digoxin also independently raises death risk, irrespective of heart failure status.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Research

Background:

  • Digoxin is a common medication for managing atrial fibrillation (AF).
  • Understanding the risks associated with digoxin use in AF patients is crucial for clinical decision-making.

Purpose of the Study:

  • To determine if digoxin use is independently associated with increased mortality in atrial fibrillation (AF) patients.
  • To investigate if heart failure or serum digoxin concentration modifies this association.

Main Methods:

  • Propensity score-adjusted analysis of 17,897 patients to assess digoxin use and mortality.
  • Analysis of new digoxin users versus matched controls.
  • Multivariable adjustment to examine serum digoxin concentration and mortality.

Main Results:

  • Baseline digoxin use was not linked to increased mortality (aHR: 1.09).
  • Serum digoxin concentration ≥1.2 ng/ml was associated with a 56% increased mortality hazard (aHR: 1.56).
  • Each 0.5-ng/ml increase in serum digoxin concentration correlated with a 19% higher mortality hazard (p=0.0010).
  • New digoxin users showed significantly higher risks of death and sudden death.

Conclusions:

  • In AF patients, digoxin use poses an independent mortality risk related to serum concentration, with highest risk at ≥1.2 ng/ml.
  • Initiating digoxin is independently associated with increased mortality in AF patients, independent of heart failure.
Abstract

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
611
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
279